GSZ23 scores based on published single-cell databases22 clearly indicated that TG2 inhibition efficiently blocked all aforementioned gluten-induced intestinal manifestations in individuals with CeD (Fig. 2d). This evidence concerns the gene TGM2 and cranioectodermal dysplasia.